Cover Image

Efficacy and Safety of Glecaprevir/Pibrentasvir in Children Aged 3–11 Years With Chronic Hepatitis C: A Real‐World, Prospective, Multicenter Study in Japan

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Tatsuki Mizuochi, Daiki Abukawa, Ayano Inui, Yoshihiro Azuma, Takako Suzuki, Hiroko Yagi, Hideki Kumagai, Sotaro Mushiake, Daisuke Tokuhara, Naoya Tsumura, Ken Kato, Yasuhito Tanaka, Hitoshi Tajiri
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Hepatology Research
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Natural history and clinical features of hepatitis C virus infection during childhood: A nationwide, observational survey in Japan
by: Satoshi Nakano, et al.
Published: (2024)

Injecting Drug Use History and Younger Age Worsen Adherence to Scheduled Hospital Visits in Glecaprevir and Pibrentasvir Therapy for Chronic Hepatitis C
by: Seiichi Tawara, et al.
Published: (2026)

Successful Retreatment of Glecaprevir‐Pibrentasvir for Hepatitis C Virus Genotype 2a Infection in Patient Whose Cirrhosis Improved From Decompensation to Compensation After Sofosbuvir–Velpatasvir Therapy
by: Tatsuo Kanda, et al.
Published: (2025)

Factors associated with low hepatitis B surface antigen levels in chronic hepatitis B patients treated with nucleot(s)ide analogs
by: Takanori Suzuki, et al.
Published: (2024)

Serum alpha‐fetoprotein/hepatocyte growth factor ratio as a novel biomarker predicting the prognosis of acute alcoholic hepatitis
by: Hiroki Inada, et al.
Published: (2025)

Evaluation of diagnostic criteria for mild‐to‐advanced stages of Fontan‐associated liver disease: A nationwide epidemiological survey in Japan
by: Tomomi Kogiso, et al.
Published: (2024)

Lipolysis‐Stimulated Lipoprotein Receptor Gene Variants as a Cause of Progressive Familial Intrahepatic Cholestasis: A Case Report
by: Yugo Takaki, et al.
Published: (2025)

Deep‐Learning‐Aided Quantification of Steatohepatitis‐Associated Pathological Findings in Liver Specimens
by: Shinji Mizuochi, et al.
Published: (2025)

Toward a Functional Cure for Chronic Hepatitis B: Current Landscape and Future Directions in Japan
by: Yutaka Handa, et al.
Published: (2026)

Steatotic Liver Disease: A Key Related Risk Factor in the Emergence of Metabolic Syndrome‐Related Disorders
by: Yoshihiro Kamada, et al.
Published: (2025)

Response to the Letter “Steatotic Liver Disease and the ‘Point of No Return’ in the Development of Metabolic Disorders”
by: Yoshihiro Kamada
Published: (2026)

Response to the Letter “Steatotic Liver Disease: A Key Related Risk Factor in the Emergence of Metabolic Syndrome‐Related Disorders”
by: Yoshihiro Kamada
Published: (2026)

SOX9 Is a Key Factor for the Postnatal Maturation of the Intrahepatic Bile Duct Network
by: Hiroki Hirao, et al.
Published: (2025)

Diagnostic Impact of Two‐Dimensional Shear Wave Elastography for Liver Fibrosis: A Multicenter Retrospective Study
by: Takashi Nishimura, et al.
Published: (2026)

MetALD Was a More Notable Independent Risk Factor for Reflux Esophagitis Than MASLD: A Multicenter Cohort Study Using Directed Acyclic Graphs
by: Hiroshi Tanaka, et al.
Published: (2025)

Response to “Which Cells Play a Protective Role in Primary Biliary Cholangitis: Dendritic Cells or Others?”
by: Jiaqi Zhang, et al.
Published: (2025)

Safety and Efficacy of Durvalumab Plus Tremelimumab in Older Individuals With Unresectable Hepatocellular Carcinoma: A Multicenter Analysis
by: Tomomitsu Matono, et al.
Published: (2025)

Analysis of autoimmune hepatitis with acute presentation in the early stage of illness
by: Keiichi Fujiwara, et al.
Published: (2024)

Long‐Term Outcomes of Sofosbuvir/Velpatasvir Treatment for Hepatitis C Virus‐Related Decompensated Cirrhosis: A Retrospective Multicenter Cohort Study
by: Satoru Kakizaki, et al.
Published: (2026)

The Hepatic Steatosis Diagnostic Performance Using Attenuation Imaging With the Magnetic Resonance Imaging‐Based Proton Density Fat Fraction as the Reference Standard: A Large, Prospective, Multicenter Cohort Study in Japan
by: Takashi Nishimura, et al.
Published: (2026)

Natural killer group 2D‐major histocompatibility complex class I polypeptide‐related sequence A activation enhances natural killer cell‐mediated immunity against hepatocellular carcinoma: A review
by: Jun Arai, et al.
Published: (2024)

The Nara Declaration: A New Collaborative Flow for Chronic Liver Disease Between Primary Care Physicians and Gastroenterologists/Hepatologists
by: Takumi Kawaguchi, et al.
Published: (2025)

Dual Escape From Ferroptosis and Disulfidptosis Denotes a Hypermetabolic, High‐Risk Subtype of Hepatocellular Carcinoma
by: Tadashi Namisaki, et al.
Published: (2026)

Imaging‐Based Surveillance of Gastroesophageal Varices in Fontan‐Associated Liver Disease: Toward a Noninvasive Strategy
by: Tadashi Namisaki, et al.
Published: (2025)

Profiles associated with significant hepatic fibrosis consisting of alanine aminotransferase >30 U/L, exercise habits, and metabolic dysfunction‐associated steatotic liver disease
by: Masahito Nakano, et al.
Published: (2024)

Refining Noninvasive Evaluation of Portal Hypertension in Biliary Atresia: Lessons From Anesthetic Conditions
by: Tadashi Namisaki, et al.
Published: (2025)

Efficacy of antiviral therapy for the prevention of mother‐to‐child transmission of hepatitis B virus and the risk of postpartum hepatitis flare after discontinuation of antiviral therapy
by: Hayato Kawamura, et al.
Published: (2024)

Brief intervention for chronic liver disease patients with alcohol use disorder in a hepatology outpatient unit: Effects and limitations
by: Nagisa Hara, et al.
Published: (2024)

Efficacy of steroid therapy for improving native liver survival after pediatric acute liver failure with immune activation
by: Hiroshi Oue, et al.
Published: (2024)

Usefulness of Automated Analysis System for Microvascular Blood Flow Rate Using Magnifying Endoscopy in Early Gastric Cancer: A Multicenter Retrospective Study (With Video)
by: Yoichi Akazawa, et al.
Published: (2025)

Impact of Surgical Resection on Hepatocellular Carcinoma Following Systemic Drug Therapy: A Multicenter Retrospective Observational Study
by: Takamichi Ishii, et al.
Published: (2025)

Multicenter observational study to characterize fibroblast growth factor receptor 2 fusions or rearrangements in patients with advanced/metastatic cholangiocarcinoma
by: Tomoyuki Satake, et al.
Published: (2025)

Hepatic arterial infusion therapy for advanced hepatocellular carcinoma after systemic treatment failure: Multicenter, real‐world study
by: Jun‐Zhe Yi, et al.
Published: (2024)

Increased Prevalence of Barrett's Esophagus in Taiwan: A Prospective Multicenter Study
by: Fu‐Jen Lee, et al.
Published: (2025)

Characteristic Hepatic Atrophy in Abemaciclib‐Induced Liver Injury: A Comparative Review of Three Cases
by: Yuwa Ando, et al.
Published: (2026)

Letter to the Editor: “Lymphocyte‐Monocyte Ratio Predicts Survival in Patients With Unresectable Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab: A Multicenter Analysis”
by: Chengli Jiang
Published: (2026)

Preventive Effect of Mineralocorticoid Receptor Antagonists Against Proteinuria Induced by Atezolizumab Plus Bevacizumab Therapy in Hepatocellular Carcinoma: A Multicenter Retrospective Study
by: Tomoki Hori, et al.
Published: (2026)

Cumulative Dose of Regorafenib in Patients With Metastatic Colorectal Cancer: A Multicenter Cohort Study
by: Yu‐Hsuan Kuo, et al.
Published: (2025)

Response to ‘Letter to the Editor: “Lymphocyte‐Monocyte Ratio Predicts Survival in Patients With Unresectable Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab: A Multicenter Analysis”’
by: Tatsuya Sakane, et al.
Published: (2026)

Increased Mortality Among Lean Versus Non‐Lean Adults With MASLD: A Multicenter Study
by: Leith Ghani, et al.
Published: (2025)